Tectonic Therapeutic Inc.

NASDAQ: TECX · Real-Time Price · USD
23.51
-0.96 (-3.92%)
At close: Aug 15, 2025, 3:59 PM
23.04
-2.00%
After-hours: Aug 15, 2025, 06:13 PM EDT

Tectonic Therapeutic Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
340K 360K 508K 424K 264K 377K 373K 371K 879K 920K 3.06M 336K 354K 399K 436K 374K 299K 291K
Gross Profit
-340K -360K -508K -424K -264K -377K -373K -371K -879K -920K -3.06M -336K -354K -399K -436K -374K -299K -291K
Operating Income
-22.33M -18.3M -13.99M -19.64M -11.42M -12.97M -9.37M -10.11M -15.73M -25.22M -25.26M -22.98M -27.77M -29.42M -27.96M -32.62M -31.38M -26.88M
Interest Income
3.39M 2.44M 1.74M 1.95M 318K 256K 133K 96K 224K 248K 87K 111K n/a n/a n/a 2K 9K 10K
Pretax Income
-19.01M -15.91M -12.37M -17.72M -12.67M -15.22M -7.87M -21.58M 67.48M -24.96M -25.03M -22.97M -28.05M -29.83M -28.23M -32.61M -31.39M -26.9M
Net Income
-19.98M -15.91M -12.37M -17.72M -12.67M -6.81M -7.87M -21.58M 67.48M -24.96M -25.03M -22.97M -28.05M -29.83M -28.23M -32.61M -31.39M -26.9M
Selling & General & Admin
5.15M 5.26M 4.83M 5.32M 4.35M 7.15M 2.18M 6.26M 3.99M 7.29M 7.12M 7.07M 8.9M 10.16M 8.96M 9.58M 8.83M 8.36M
Research & Development
17.18M 13.04M 9.15M 14.32M 7.07M 463K 7.19M 14.83M 10.86M 17M 15.08M 15.58M 18.52M 18.85M 18.56M 22.67M 22.25M 18.24M
Other Expenses
n/a n/a 1K n/a n/a 5.35M n/a n/a -8K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
22.33M 18.3M 13.99M 19.64M 11.42M 12.97M 9.37M 21.09M 14.85M 24.3M 22.2M 22.65M 27.42M 29.02M 27.53M 32.25M 31.08M 26.59M
Interest Expense
17K 20K 22K 25K 28K 31K 34K 36K 40K n/a 34K n/a 285K 370K 245K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a 5M n/a 4.17M 2.13M 5.75M 5.05M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
22.33M 18.3M 13.99M 19.64M 11.42M 12.97M 9.37M 21.09M 15.73M 25.22M 25.26M 22.98M 27.77M 29.42M 27.96M 32.62M 31.38M 26.88M
Income Tax Expense
976K n/a n/a n/a n/a -377K n/a n/a n/a n/a n/a n/a n/a n/a n/a -0.00 n/a n/a
Shares Outstanding (Basic)
18.68M 17.16M 14.79M 5.71M 2.92M 3.73M 3.72M 3.71M 3.68M 3.67M 3.65M 3.65M 3.64M 3.64M 3.64M 3.64M 3.55M 3.47M
Shares Outstanding (Diluted)
18.68M 17.16M 14.79M 5.71M 2.92M 3.73M 3.72M 3.71M 3.69M 3.67M 3.65M 3.65M 3.64M 3.64M 3.64M 3.64M 3.55M 3.47M
EPS (Basic)
-1.07 -0.93 -0.84 -3.11 -4.34 -1.82 -2.36 -0.68 18.35 -6.8 -6.86 -6.3 -7.7 -8.19 -7.76 -8.97 -8.84 -7.76
EPS (Diluted)
-1.07 -0.93 -0.84 -3.11 -4.34 -1.82 -2.36 -0.68 18.29 -6.8 -6.86 -6.3 -7.7 -8.19 -7.76 -8.97 -8.84 -7.76
EBITDA
-22.33M -15.53M -11.84M -17.27M -12.38M -14.81M -7.46M -9.65M -10.26M -24.04M -10.02M -22.63M -27.41M -29.06M -27.55M -32.24M -31.09M -26.61M
EBIT
-18.99M -15.89M -12.35M -17.69M -12.64M -15.19M -7.83M -10.02M -10.41M -24.96M -10.26M -22.97M -27.77M -29.46M -27.98M -32.61M -31.39M -26.9M
Depreciation & Amortization
340K 360K 508K 424K 264K 377K 373K 371K 879K 920K 3.06M 336K 354K 399K 436K 374K 299K 291K